iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB)

CAPS Rating: 4 out of 5

Exchange Traded Funds

Results 1 - 20 of 36 : 1 2 Next »

Recs

0
Member Avatar derbydog85 (< 20) Submitted: 4/4/2016 7:11:52 PM : Outperform Start Price: $268.56 IBB Score: -1.04

recent double bottom...buy time

Recs

0
Member Avatar TerryHoodSr (62.85) Submitted: 2/3/2016 10:47:07 AM : Outperform Start Price: $253.63 IBB Score: -3.95

IBB 255 TP 380 52wk 251-400
Top holdings include some of the most respected names in biotech: Celgene, Biogen, Amgen, Gilead Sciences, and Regeneron Pharmaceuticals.

Recs

0
Member Avatar graybell (< 20) Submitted: 1/28/2016 1:34:41 PM : Outperform Start Price: $264.35 IBB Score: -7.64

oversold

Recs

0
Member Avatar optioncoach (90.24) Submitted: 1/4/2016 3:00:07 PM : Outperform Start Price: $325.02 IBB Score: -21.13

Biotech Pull back. Does China have anything to do with Biotechs?... anyway. 3.5% pull back and I think you have to try to get some solid positions on.

Recs

0
Member Avatar alansfinance (42.98) Submitted: 1/3/2016 8:52:43 PM : Outperform Start Price: $330.96 IBB Score: -21.95

Time of the year to b ebuying Biotechs

Recs

0
Member Avatar motto1628 (< 20) Submitted: 10/6/2015 3:08:45 PM : Outperform Start Price: $301.62 IBB Score: -15.48

aging population

Recs

0
Member Avatar manirg (< 20) Submitted: 8/6/2015 12:06:59 PM : Outperform Start Price: $369.83 IBB Score: -26.58

beaten down

Recs

1
Member Avatar mhammond00 (< 20) Submitted: 4/4/2015 10:57:41 PM : Outperform Start Price: $341.65 IBB Score: -22.04

If the previous 30 years were dominated by a semiconductor / IT revolution, the next 30 will be dominated by biotech. I'm a scientist working now at a large biotech, but I'm not a biologist by training (I'm a physicist - used to work in semiconductors). I can tell you that the pace of technology innovation in biotech right now is nothing short of breathtaking. Medicine will be completely transformed 20-30 years from now. While I'm not smart enough to know which micro or small cap biotech will or won't make it, biotech ETF's like IBB, FBT, etc are a great way to ride this wave, and will continue to destroy the broader market for the next decades. I cannot emphasize this enough - the scientific tools are now in place to understand and manipulate biology in ways that will completely transform medicine as we know it.

Recs

2
Member Avatar DrGoldin (99.66) Submitted: 1/22/2015 3:24:33 PM : Outperform Start Price: $317.11 IBB Score: -17.83

Almost every day you read about some breakthrough results from a biotech company you've never heard of. What better way to make sure you get a piece of all that than to buy the biggest biotech ETF?

Recs

0
Member Avatar Sophos2 (70.20) Submitted: 12/2/2014 3:10:03 PM : Underperform Start Price: $306.69 IBB Score: +12.21

OVERBOUGHT

Recs

0
Member Avatar theredtomato (64.19) Submitted: 6/8/2014 2:51:27 PM : Outperform Start Price: $245.91 IBB Score: +3.34

Biotech is poised to better the market over the next 5 years. IBB should do a bit better than the general biotech industry because of its focus on larger equities.

Recs

0
Member Avatar rofgile (99.29) Submitted: 1/15/2014 10:17:24 PM : Outperform Start Price: $243.47 IBB Score: -1.91

Science and drug development are not doing well, but biotech and life sciences companies are on a tear!

Recs

2
Member Avatar aaronsadowsky (< 20) Submitted: 9/5/2013 9:21:56 AM : Outperform Start Price: $201.48 IBB Score: +8.58

This is my first CAP and IBB did well yday

Recs

0
Member Avatar garrah (< 20) Submitted: 5/12/2013 8:38:42 PM : Outperform Start Price: $179.48 IBB Score: +22.86

Biotech is a safety net for now until energy cost catches up to demand,

Recs

1
Member Avatar EmmyKaye (33.06) Submitted: 4/24/2013 5:03:50 PM : Outperform Start Price: $170.86 IBB Score: +26.52

Bio tech will continue to lead the market

Recs

1
Member Avatar SamsaricSufferer (< 20) Submitted: 7/4/2012 8:35:17 PM : Outperform Start Price: $133.19 IBB Score: +50.47

Biotechs are strong this year.

Recs

2
Member Avatar ravens9111 (< 20) Submitted: 3/26/2012 6:13:47 PM : Outperform Start Price: $123.45 IBB Score: +71.47

Playing individual biotech stocks is risky business. This is probably the least risky way to play the sector without taking a chance of waking up one morning to see the company's drug was rejected and opens down 50%+ on an FDA rejection.

Recs

0
Member Avatar bIlluminati (31.85) Submitted: 3/2/2012 2:44:31 PM : Underperform Start Price: $118.91 IBB Score: -75.09

Price action here just looks off.

Recs

1
Member Avatar Mary953 (73.92) Submitted: 7/10/2011 3:13:41 PM : Outperform Start Price: $108.23 IBB Score: +92.15

My choices in Biotech are an absolute disaster. Nonetheless, I realize that the sector has some wonderful successes and the needs of the boomer generation plus some "newly discovered" illnesses require new medicines. That makes Biotech a sector to have a presence in.

Porte is our resident expert in this area and I am choosing this at his suggestion. It is worth noting that the only Biotech firms that have ever rewarded me - on CAPS or RL - are the ones that Porte has suggested to me. His suggestions are enough for me to add this to CAPS if not to add RL funds to.

Recs

0
Member Avatar Biotech2010 (< 20) Submitted: 1/26/2010 8:52:06 PM : Outperform Start Price: $81.19 IBB Score: +141.02

84.25

Results 1 - 20 of 36 : 1 2 Next »

Featured Broker Partners